NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

23 hedge funds and large institutions have $337K invested in InVivo Therapeutics Holdings Corp in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$241K
2
UBS Group
2
UBS Group
Switzerland
$7K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
ICM
2
IMS Capital Management
Oregon
$0
3
WS
3
Wedbush Securities
California
$0
4
Deutsche Bank
4
Deutsche Bank
Germany
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$2K
Name Market Value Shares Shares
Change 		Shares
Change %
AG
26
Advisor Group
Arizona
$0 923 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
CBT
28
Capital Bank & Trust
California
$0 8 +8 New
AIC
29
Ameritas Investment Company
Nebraska
$0 35 +35 New
1
2